SUSRF vs JNJ: Which Stock is Better?

Side-by-side comparison of Surgical Science Sweden AB (publ) and Johnson & Johnson in 2026

Comparison Updated:

SUSRF

Surgical Science Sweden AB (publ)

$2.84

JNJ

Johnson & Johnson

$234.18

Key Metrics Comparison

MetricSUSRFJNJWinner
Market Cap$150.36M$565.22BJNJ
P/E Ratio20.2921.26SUSRF
EPS (TTM)$0.14$11.03JNJ
Revenue Growth0.1%0.1%JNJ
Gross Margin66.6%68.0%JNJ

Analyze SUSRF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SUSRF or JNJ a better investment?

Comparing SUSRF and JNJ: Surgical Science Sweden AB (publ) has a market cap of $150.36M while Johnson & Johnson has $565.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SUSRF and JNJ?

SUSRF (Surgical Science Sweden AB (publ)) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SUSRF or JNJ?

Based on P/E ratios, SUSRF trades at a lower multiple (20.3x vs 21.3x).

Which is growing faster: SUSRF or JNJ?

JNJ has higher revenue growth at 0.1% vs 0.1% for SUSRF.

Which company is more profitable: SUSRF or JNJ?

Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 66.6% for SUSRF.

Which is the larger company: SUSRF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $565.22B compared to $150.36M for SUSRF.

Should I buy SUSRF or JNJ in 2026?

Both SUSRF and JNJ have investment merit. SUSRF trades at $2.84 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SUSRF and JNJ stock?

Key differences: Market Cap ($150.36M vs $565.22B), P/E Ratio (20.3x vs 21.3x), Revenue Growth (0.1% vs 0.1%), Gross Margin (66.6% vs 68.0%).

Popular Stock Comparisons